Finance, News

Study Shows That Medicare Coverage of Novo’s Semaglutide for CVD Could Cost $145 Billion Per Year

• Anthony DiMoro
• August 27, 2024

Finance, News

Medicare Reimbursement For Breast Surgery Showing Steady Decline

• Anthony DiMoro

Finance, News

Medicare Drug Price Cuts Could Be Limited Early, But Grow Over Time

• Anthony DiMoro
• August 21, 2024

Finance, News

Medicaid Overtakes Medicare Advantage in Q2 Earnings

• Anthony DiMoro